10mM in DMSO for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
🌡
Storage & shipping
Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
📋
Quality documents
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
📚
Literature proof
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Vue d’ensemble
BA-53038B is a HBV core protein allosteric modulator (CpAM) , binding to the HAP pocket and modulating HBV capsid assembly. BA-53038B has antiviral activity for hepatitis B virus (HBV) with an EC 50 value of 3.32 μM. BA-53038B can be used for the research of chronic hepatitis B
In Vitro
BA-53038B has antiviral activity for HBV with an EC 50 value of 3.32 μM. BA-53038B has cytotoxicity with CC 50 value of >100 μM. BA-53038B (5 μM; 48 h) induces the capsid/nucleocapsid mobility shift and reduced the amount of hypophosphorylated core protein. BA-53038B (0-20 μM; 2 or 6 days) inhibits HBV nucleocapsid assembly. BA-53038B (5 μM; 2 days) inhibits pgRNA encapsidation and consequentially reduces the amount of DNA-containing capsids and hypophosphorylated core protein. BA-53038B (2 μM; 6 h) modulates HBV capsid assembly by binding to the HAP pocket. BA-53038B has resistant effect with an EC 50 value of >10 μM on HBV capsid (HepG2 cells transiently transfected pHBV1.3/core-V124W). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: AML12HBV10 cells Concentration: 5 μM Incubation Time: 48 h Result: Reduced the amount of hypophosphorylated core protein and promoted the assembly of empty capsids with slow electrophoresis mobility. RT-PCRCell Line: AML12HBV10 and HepDES19 cells Concentration: 0-20 μM Incubation Time: 2 or 6 days Result: Inhibited HBV replication in both AML12HBV10 and HepDES19 cells.
IC50& Target:EC 50: 3.32 μM (HBV)
Specifications
Spécifications et pureté
10mM in DMSO
Mécanismes biochimiques et physiologiques
BA-53038B is a HBV core protein allosteric modulator (CpAM) , binding to the HAP pocket and modulating HBV capsid assembly. BA-53038B has antiviral activity for hepatitis B virus (HBV) with an EC 50 value of 3.32 μM. BA-53038B can be used for the research
Conditions de stockage de stockage
Store at -80°C
Expédié en
Dry ice packs + Cold packs
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Type d'action
INHIBITOR
Noms et identifiants
PubChem CID
138454763
Poids moléculaire
249.74
Documentation
📋 Safety Data Sheet (SDS)
Comprehensive hazard, handling, storage, and regulatory compliance document.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
